Skip to content

Omeros OMER Principal Payments On Royalty Obligations

Principal Payments On Royalty Obligations at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$476K
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$476K
Alpha and Omega Semiconductor logo
Alpha and Omega SemiconductorAOSL
$233.75K+7.8%
Mannkind logo
MannkindMNKD
$279K+39.5%
BH
Biglari Holdings Inc.BH
$1.81M+29.4%
US Foods logo
US FoodsUSFD
$2.43B+102%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept omer:PrincipalPaymentsOnRoyaltyObligations.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's principal payments on royalty obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's principal payments on royalty obligations?
Omeros (OMER) reported principal payments on royalty obligations of $4.67M in Q1 2026.
How has Omeros's principal payments on royalty obligations changed year-over-year?
Omeros's principal payments on royalty obligations increased by 171.2% year-over-year, from $1.72M to $4.67M.
What does principal payments on royalty obligations mean?
Captures the actual cash payments made to satisfy the principal portion of royalty-based financing liabilities. Unlike interest expense, these payments represent the reduction of the underlying debt obligation tied to future product revenues. This is vital for assessing the company's progress in extinguishing royalty-linked debt.